Lindborg Stacy 4
4 · Imunon, Inc. · Filed Sep 9, 2025
Insider Transaction Report
Form 4
Imunon, Inc.IMNN
Lindborg Stacy
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-09-06+1,667→ 3,584 total - Exercise/Conversion
Restricted Stock
2025-09-06−1,667→ 0 total→ Common Stock (1,667 underlying)
Holdings
- 234(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]Acquisition of common stock resulting from vesting of 100% of the restricted stock granted to Ms. Lindborg on September 6, 2024.
- [F2]Each restricted stock share represents a contingent right to receive one share of Imunon, Inc.'s common stock.
- [F3]On September 6, 2024, Ms. Lindborg received restricted stock representing 1,667 shares (as adjusted for the reverse stock split) subject to a one-year vesting schedule, vesting 100% on the first anniversary of the grant date. As restricted stock shares vest, the vested shares are automatically converted to vested common stock on a one-for-one basis on the vesting date.